A
NUVB icon

AJOVista’s Nuvation Bio NUVB Stock Holding History

AJOVista’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,295
Closed -$65.1K – 157
2024
Q2 		$65.1K Buy
+22,295
New +$68K 0.19% 63

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

AJOVista's NUVB Position: Q3 2024 in Review

AJOVista sold out of Nuvation Bio (NUVB) in Q3 2024, closing a stake of 22,295 shares — an estimated $65.1K sold.

AJOVista first reported a position in NUVB in Q2 2024 and held it in 1 quarter. The position peaked at $65.1K in Q2 2024. 154 funds tracked by Wall St. Rank hold NUVB as of Q3 2024.

  • AJOVista reported no remaining Nuvation Bio position as of Q3 2024 after selling out during the quarter.
  • AJOVista sold 22,295 Nuvation Bio shares in Q3 2024, an estimated $65.1K.
  • AJOVista first reported a position in Nuvation Bio in Q2 2024 and held it in 1 quarter.
  • AJOVista's Nuvation Bio position peaked at $65.1K in Q2 2024.
  • 154 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.